Antimicrobial Agents Practice Questions

Q: Which of the following is the longest acting carbapenem?

Ertapenem. ***Ertapenem*** - **Ertapenem** has the **longest half-life** among the carbapenems, allowing for once-daily dosing. - Its prolonged action is due to its **chemical structure**, which provides high protein binding and reduced renal clearance compared to other carbapenems. *Imipenem* - **Imipenem** has a **relatively short half-life** and requires co-administration with cilastatin to prevent its renal metabolism by dehydropeptidase-1. - Its short duration of action necessitates **frequent dosing**, typically every 6 to 8 hours. *Meropenem* - **Meropenem** has a **shorter half-life** than ertapenem, generally requiring dosing every 8 hours. - Although it does not require cilastatin, its pharmacokinetic profile is not as extended as ertapenem's. *Doripenem* - **Doripenem** also has a **shorter half-life** than ertapenem, necessitating administration every 8 hours. - Its spectrum of activity is similar to meropenem, but it does not offer the same extended duration of action.

Q: What is the recommended single dose treatment for gonorrhea?

Ceftriaxone. ***Ceftriaxone*** - **Ceftriaxone** is the **recommended first-line single dose treatment** for uncomplicated gonorrhea, given as a **500 mg intramuscular injection**. - As per current guidelines (CDC 2020+), **ceftriaxone monotherapy** is preferred due to its high efficacy and the discontinuation of routine dual therapy. - Ceftriaxone, a third-generation cephalosporin, maintains excellent activity against *Neisseria gonorrhoeae* with minimal resistance reported. *Azithromycin* - **Azithromycin alone** is **not recommended** as single-dose monotherapy for gonorrhea due to increasing macrolide resistance and treatment failures. - While previously used in dual therapy with ceftriaxone, routine dual therapy was discontinued in 2020 guidelines. - Azithromycin remains the first-line treatment for **chlamydia** (1 g single dose), which often co-occurs with gonorrhea and should be treated separately if detected. *Tetracycline* - **Tetracycline** is **not effective** against current strains of *Neisseria gonorrhoeae* due to widespread resistance. - Tetracyclines are primarily used for bacterial infections like **chlamydia** (doxycycline 100 mg twice daily for 7 days), **acne**, and **rickettsial infections**. *Erythromycin* - **Erythromycin** is **not a recommended treatment** for gonorrhea due to high rates of resistance and poor efficacy. - It is used for conditions like **streptococcal pharyngitis** in penicillin-allergic patients and some **atypical pneumonias**.

Q: Which drug would be most appropriate for treating a patient with suspected chlamydia-gonorrhea coinfection?

Doxycycline. ***Doxycycline*** - **Doxycycline** is a highly effective treatment for **chlamydia**, and its broad-spectrum activity also covers potential **gonorrhea coinfection** when used as part of a dual therapy regimen. - It is often prescribed alongside a **single dose of ceftriaxone** for presumed gonorrhea coinfection, as ceftriaxone targets gonorrhea while doxycycline targets chlamydia. *Ciprofloxacin* - **Ciprofloxacin** is a **fluoroquinolone** antibiotic, which is generally not recommended as first-line treatment for uncomplicated **gonorrhea** or **chlamydia** due to increasing resistance. - It has activity against *Neisseria gonorrhoeae*, but its effectiveness against *Chlamydia trachomatis* is suboptimal compared to macrolides or tetracyclines. *Norfloxacin* - **Norfloxacin** is another **fluoroquinolone** with a narrower spectrum of activity than ciprofloxacin and is primarily used for **urinary tract infections**. - It has **poor efficacy against chlamydia** and is not a recommended treatment for either organism in this context. *Nalidixic acid* - **Nalidixic acid** is a first-generation **quinolone** with a very limited spectrum, used mainly for **gram-negative urinary tract infections**. - It has **no significant activity against chlamydia** or gonorrhea and is therefore inappropriate for treating this suspected coinfection.

Q: What is the treatment for Trichomonas vaginalis?

Metronidazole. ***Metronidazole*** - **Metronidazole** is the **first-line drug** for treating *Trichomonas vaginalis* infection. - It is effective against this **anaerobic protozoan** and can be administered as a single dose or a 7-day course. *Azithromycin* - **Azithromycin** is a **macrolide antibiotic** primarily used to treat bacterial infections, such as **chlamydia** or certain **respiratory tract infections**. - It is **not effective** against *Trichomonas vaginalis*, which is a parasitic protozoan. *Ciprofloxacin* - **Ciprofloxacin** is a **fluoroquinolone antibiotic** used for bacterial infections, especially **urinary tract infections** and complicated **gastrointestinal infections**. - It has **no activity** against *Trichomonas vaginalis*. *None of the options* - This option is incorrect because **Metronidazole** is a highly effective and widely accepted treatment for *Trichomonas vaginalis* infections.

Q: What is the drug of choice for the treatment of kala-azar?

Liposomal Amphotericin B. ***Liposomal Amphotericin B*** - It is currently considered the **drug of choice** for treating **visceral leishmaniasis (kala-azar)** due to its high efficacy and better tolerability profile compared to conventional amphotericin B. - The **liposomal formulation** allows for targeted delivery to macrophages, where *Leishmania* parasites reside, reducing systemic toxicity. *Amphotericin B* - While effective against *Leishmania*, conventional **Amphotericin B deoxycholate** is associated with significant **nephrotoxicity** and other severe side effects. - It is generally reserved for cases where liposomal amphotericin B is unavailable or as an alternative in specific clinical situations. *Quinine* - **Quinine** is an **antimalarial drug** primarily used for the treatment of *Plasmodium falciparum* malaria. - It has no significant efficacy against *Leishmania* species, which are the causative agents of kala-azar. *Paromomycin* - **Paromomycin** is an **aminoglycoside antibiotic** that can be used as an alternative treatment for visceral leishmaniasis, especially in combination therapies. - Although effective, it is generally not considered the first-line **drug of choice** globally, and its efficacy can vary by region.

Q: Which drug is commonly used to treat chronic hepatitis B infection?

Entecavir. ***Entecavir*** - **Entecavir** is an oral **nucleoside analog reverse transcriptase inhibitor** specifically approved and widely used for the treatment of **chronic hepatitis B virus (HBV) infection**. - It works by inhibiting HBV DNA polymerase, thereby reducing **viral replication** and preventing disease progression. *Atazanavir* - **Atazanavir** is a **protease inhibitor** primarily used in the treatment of **HIV infection**. - It is not indicated for the treatment of **hepatitis B virus infection**. *Zanamivir* - **Zanamivir** is a **neuraminidase inhibitor** used in the treatment and prevention of **influenza A and B viruses**. - It has no activity against **hepatitis B virus**. *Abacavir* - **Abacavir** is a **nucleoside reverse transcriptase inhibitor (NRTI)** used to treat **HIV infection**. - While it is an NRTI, it does not have significant efficacy against **hepatitis B virus** and is not used for its treatment.

Q: Which of the following conditions is not treated by penicillin G?

Rickettsial infection. ***Rickettsial infection*** - **Rickettsial infections**, such as Rocky Mountain spotted fever or typhus, are caused by **obligate intracellular bacteria** that are not susceptible to penicillin G. - The primary treatment for rickettsial infections is **doxycycline**, due to its ability to penetrate host cells and inhibit bacterial protein synthesis. *Bacterial meningitis* - **Bacterial meningitis**, particularly caused by susceptible strains of *Neisseria meningitidis*, *Streptococcus pneumoniae*, and *Haemophilus influenzae*, can be effectively treated with **high-dose intravenous penicillin G** [1]. - Penicillin G's ability to cross the **blood-brain barrier** in inflamed meninges makes it a suitable option, though ceftriaxone is now more commonly used empirically due to resistance concerns [2]. *Syphilis* - **Penicillin G** remains the **drug of choice** for all stages of syphilis, caused by *Treponema pallidum*. - For primary, secondary, and early latent syphilis, a **single intramuscular dose of benzathine penicillin G** is curative. *Anthrax* - While **ciprofloxacin** and **doxycycline** are often considered first-line for anthrax, **penicillin G** can also be an effective treatment for susceptible strains of *Bacillus anthracis*. - It is particularly used in cases of less severe cutaneous anthrax or to de-escalate treatment once susceptibility is confirmed.

Q: Drug for prophylaxis of malaria in chloroquine resistant P.falciparum ?

Mefloquine. ***Mefloquine*** - **Mefloquine** is a well-established and effective drug for prophylaxis against **chloroquine-resistant Plasmodium falciparum**. - It is often used in regions with high chloroquine resistance, although it can have significant neuropsychiatric side effects. *Quinine* - **Quinine** is primarily used for the *treatment* of severe or complicated malaria, especially in cases of multidrug resistance. - It is not typically recommended for malaria **prophylaxis** due to its relatively short half-life and potential for side effects with chronic use. *Halofantrine* - **Halofantrine** is an *antimalarial treatment* drug, not a prophylactic agent. - Its use is limited due to potential for **cardiotoxicity** (QT prolongation) and poor bioavailability. *Artesunate* - **Artesunate** is an **artemisinin derivative** and a potent antimalarial drug used for the *treatment* of acute malaria, particularly severe cases. - It has a very short half-life and is not suitable for **prophylaxis**.

Q: Which of the following is a topical sulfonamide ?

Mafenide. ***Mafenide*** - **Mafenide** is a **sulfonamide antibiotic** primarily used **topically** as a cream for preventing and treating **wound infections**, particularly in **burn patients**. - It works by inhibiting bacterial growth and has good penetrative capabilities in **necrotic tissue** and **eschar**. - It is **water-soluble** and can penetrate burn eschar effectively. *Sulfadoxine* - **Sulfadoxine** is a **long-acting oral sulfonamide** frequently used in combination with **pyrimethamine** for conditions like **malaria** and **toxoplasmosis**. - It is administered **systemically**, not topically. *Sulfamethopyrazine* - **Sulfamethopyrazine** (also known as sulfalene) is another **long-acting sulfonamide** primarily used **orally** for conditions such as **malaria** and **urinary tract infections**. - Its clinical application is **systemic**, not topical. *Sulfisoxazole* - **Sulfisoxazole** is a **short-acting oral sulfonamide** used systemically for **urinary tract infections** and other bacterial infections. - It is **rapidly absorbed** and excreted, making it suitable for systemic use, not topical application.

Q: What is the mechanism of action of aminoglycoside antibiotics?

Inhibition of protein synthesis. ***Inhibition of protein synthesis*** - Aminoglycosides **bind irreversibly to the 30S ribosomal subunit** of bacteria, interfering with the initiation complex formation and causing misreading of mRNA. - This leads to the production of **non-functional proteins** and ultimately bacterial cell death, making them bactericidal. *Disruption of the cell membrane* - This mechanism is characteristic of **polymyxins** (e.g., colistin), which interact with bacterial cell membranes, increasing permeability and causing leakage of intracellular contents. - Aminoglycosides do not primarily target the cell membrane for their bactericidal action. *Inhibition of DNA replication* - This mechanism is associated with **fluoroquinolones**, which inhibit bacterial topoisomerase II (DNA gyrase) and topoisomerase IV. - Aminoglycosides do not interfere with DNA synthesis or replication. *Inhibition of bacterial cell wall synthesis* - This is the mechanism of action for **beta-lactam antibiotics** (e.g., penicillins, cephalosporins) and **glycopeptides** (e.g., vancomycin), which target peptidoglycan synthesis. - Aminoglycosides do not affect the bacterial cell wall but rather their intracellular protein machinery.

Question 1

Which of the following is the longest acting carbapenem?

Accepted Answer

Ertapenem

Answer

Imipenem

Answer

Meropenem

Answer

Doripenem

Question 2

What is the recommended single dose treatment for gonorrhea?

Accepted Answer

Ceftriaxone

Answer

Erythromycin

Answer

Tetracycline

Answer

Azithromycin

Question 3

Which drug would be most appropriate for treating a patient with suspected chlamydia-gonorrhea coinfection?

Accepted Answer

Doxycycline

Answer

Ciprofloxacin

Answer

Nalidixic acid

Answer

Norfloxacin

Question 4

What is the treatment for Trichomonas vaginalis?

Accepted Answer

Metronidazole

Answer

Azithromycin

Answer

Ciprofloxacin

Answer

None of the options

Question 5

What is the drug of choice for the treatment of kala-azar?

Accepted Answer

Liposomal Amphotericin B

Answer

Amphotericin B

Answer

Quinine

Answer

Paromomycin

Question 6

Which drug is commonly used to treat chronic hepatitis B infection?

Accepted Answer

Entecavir

Answer

Zanamivir

Answer

Atazanavir

Answer

Abacavir

Question 7

Which of the following conditions is not treated by penicillin G?

Accepted Answer

Rickettsial infection

Answer

Bacterial meningitis

Answer

Syphilis

Answer

Anthrax

Question 8

Drug for prophylaxis of malaria in chloroquine resistant P.falciparum ?

Accepted Answer

Mefloquine

Answer

Quinine

Answer

Halofantrine

Answer

Artesunate

Question 9

Which of the following is a topical sulfonamide ?

Accepted Answer

Mafenide

Answer

Sulfadoxine

Answer

Sulfamethopyrazine

Answer

Sulfisoxazole

Question 10

What is the mechanism of action of aminoglycoside antibiotics?

Accepted Answer

Inhibition of protein synthesis

Answer

Inhibition of DNA replication

Answer

Disruption of the cell membrane

Answer

Inhibition of bacterial cell wall synthesis

Antimicrobial Agents — MCQs

Antimicrobial Agents — MCQs

On this page

Practice by Chapter

Want unlimited practice?